Robotic surgery has become a clinical norm in the world’s leading hospitals after only two decades of its inception. Much of that is driven by the da Vinci Surgical System, which provides surgeons with greater precision, a clearer view of the operation, and more control over their instruments than traditional laparoscopy offers. Its applications range from urology, gynecology, and thoracic surgery to other areas, carving it as one of the most consequential platforms in modern surgical care.
The da Vinci Surgical System is a robot-assisted surgical platform developed by Intuitive Surgical and first cleared by the US Food and Drug Administration for human use in 2000. It has since become the world's dominant robotic surgical platform, with nearly 1.6 million procedures performed using da Vinci systems in 2021 alone.1
Four key components form the system: a surgeon’s console, a patient-side cart with four interactive robotic arms, a high-definition vision system, and the patented EndoWrist instruments.
The surgeon sits at the console in the same operating room and guides the robotic arms using hand controls and foot pedals while viewing a magnified, three-dimensional image of the surgical site. This closed-console design provides surgeons with an image that enables them to feel as if they are in direct proximity to the operative site.2,3
What sets da Vinci apart from conventional laparoscopy is its seven degrees of freedom, which replicate the natural rotation and dexterity of a human wrist, with far greater range than the four degrees of freedom available to standard laparoscopic instruments.1
Conventional tools pivot around a fixed incision point and cannot bend or rotate freely within the body, limiting precise movement in tight anatomical spaces where critical structures cluster. The da Vinci EndoWrist technology also incorporates a tremor-filtration system, smoothing out involuntary hand movements before they translate into instrument motion inside the patient's body.1
How the Technology Works
During a da Vinci procedure, surgeons make one to four small port incisions, typically eight millimeters in diameter, through which the robotic instruments and an endoscopic camera are introduced. The camera projects a high-definition, three-dimensional view of the operative site onto the surgeon's console, offering magnification far beyond what the naked eye can achieve during open surgery. This visual clarity ensures that surgeons do not lose their sense of orientation during the surgical procedure.2,3
The surgeon’s movements at the console are transmitted to the instruments in real time via a motion-scaling function. If a surgeon moves their hand one centimeter, the robot translates that motion into a fraction of a millimeter at the instrument tip, enabling unmatched precision in manipulating delicate tissues. This level of control proves especially valuable in confined anatomical regions like the pelvis, where nerve-sparing techniques during prostatectomy or rectal resection demand exacting surgical accuracy.1
A scrubbed bedside assistant is present throughout every da Vinci procedure. This assistant manages instrument exchanges, provides suction or countertraction with conventional tools, and is prepared to facilitate conversion to laparoscopic or open surgery if required. This human safety layer means da Vinci surgery operates as a cooperative, surgeon-directed process rather than an autonomous one.3
Procedures It Covers
The da Vinci system is used in a wide variety of surgical fields. In urology, robotic-assisted radical prostatectomy became the preferred minimally invasive approach for prostate cancer. By 2017–2019, 88% of all radical prostatectomies were performed robotically throughout the UK. Beyond prostatectomy, the platform supports partial and radical nephrectomy, cystectomy, and pyeloplasty, all with documented outcomes improvements in peer-reviewed literature.1
In gynecology, the system supports hysterectomy, myomectomy, and ovarian cystectomy, with a review of 34 studies confirming lower blood loss, lower conversion to open surgery, and shorter hospital stays compared with open approaches.
General surgical applications include hernia repair, cholecystectomy, and colorectal resection, where multiple evidence reviews show reduced surgical site infection rates and lower postoperative ileus rates. The robotic approach in colorectal surgery has also demonstrated lower 30-day reoperation rates compared to open surgery across large multicenter datasets.4
Thoracic and head-and-neck surgery have also been integrated into the da Vinci platform. Transoral robotic surgery enables tumor resection in the oropharynx through the mouth without any external incision, reducing visible scarring and expediting swallowing and speech recovery postoperatively. An analysis of 29 studies on robotic thymectomy found fewer ICU admissions, lower blood loss, and shorter chest tube duration compared to open thoracic surgery.2,4
Benefits of da Vinci Surgery
The most consistent benefit in clinical presentation is a decrease in the intraoperative blood loss. Robotic instruments allow surgeons to dissect and cauterize with submillimeter accuracy, minimizing unintended vascular injury throughout the procedure. A large evidence review of 55 studies on rectal resection found that da Vinci robotic-assisted surgery was associated with lower blood loss, fewer blood transfusions, and lower 30-day mortality compared with both laparoscopic and open surgical approaches.4
Smaller incisions directly correlate with reduced tissue trauma, reduced postoperative pain, and reduced analgesic needs post-surgery. The COMPARE Study found that da Vinci robotic-assisted surgery carried a 30-day complication risk 44% lower than open surgery and 10% lower than laparoscopic or video-assisted thoracic procedures, reflecting consistent safety advantages across surgical modalities.5
Functional preservation in pelvic surgery is among the most studied advantages of the system. A high-quality randomized controlled trial demonstrated that robotic rectal cancer surgery produced significantly better urinary, sexual, and defecation function in the first postoperative year compared to conventional laparoscopy, with perioperative complication rates of 16.1% versus 22.9% favoring the robotic group.
Enhanced three-dimensional visualization allows surgeons to identify and protect pelvic autonomic nerve bundles with a clarity that flat-screen laparoscopy cannot replicate.6
Surgeon ergonomics represent an underappreciated factor with direct consequences for patient safety. In conventional laparoscopy, surgeons hold instruments at biomechanically disadvantageous angles for hours, accumulating shoulder, hand, and wrist strain over a surgical career.
With da Vinci, the surgeon works from a seated, ergonomically designed console, reducing physical fatigue and sustaining precision across lengthy procedures without postural degradation in performance.1,2
Risks and Limitations
The da Vinci system carries documented risks that are essential to understand before choosing it. Instrument malfunction is the most frequently reported technical failure, yet a systematic review pooling data from over 3.3 million procedures found an overall malfunction rate of 1.0%, with malfunction-related injuries occurring in just 0.01% of cases. Conversion to open or laparoscopic surgery due to malfunction was required in only 0.09% of all procedures.7
Positioning-related complications are a separate risk category. To move abdominal contents out of the operative area, Da Vinci surgeries often involve placing patients in the steep Trendelenburg posture with their heads tilted downwards at angles of 30 degrees or more.
Saving this for later? Download a PDF here.
This positioning has been associated with corneal abrasion, visual loss, peripheral nerve palsy, and rhabdomyolysis, in which skeletal muscle breakdown releases proteins that can damage the kidneys. Both Trendelenburg angle and duration should be limited per guidelines, especially in patients with cardiac or ophthalmic risk factors before surgery.1
Longer operative times are a consistent and well-documented trade-off. Reviews of colorectal, urological, and thoracic procedures show that robotic surgery takes longer than both laparoscopic and open approaches, increasing anesthesia duration and immobilization time. Cost adds another layer - the da Vinci Xi retails at approximately $1.75 million USD, with per-procedure costs exceeding $8,000, creating access inequities between high-volume academic centers and lower-resourced hospitals worldwide.1,4
Lack of haptic feedback is a primary technical constraint. The absence of “feel” is a fundamental technical limitation of haptics – the surgeon cannot feel tissue resistance, tension, or texture through the instruments and must visually estimate the applied force. This reliance heightens the risk of inadvertent injury near fragile vessels or in fibrotic tissue, and surgeons develop compensatory visual awareness only through structured training programs and deliberate accumulation of operative experience over time.2,3
References and Further Reading
- Hughes, T. et al. (2023). The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery. Journal of Clinical Medicine, 12(6), 2268. DOI:10.3390/jcm12062268. https://www.mdpi.com/2077-0383/12/6/2268
- Reddy, K. et al. (2023). Advancements in Robotic Surgery: A Comprehensive Overview of Current Utilizations and Upcoming Frontiers. Cureus, 15(12), e50415. DOI:10.7759/cureus.50415. https://www.cureus.com/articles/191019-advancements-in-robotic-surgery-a-comprehensive-overview-of-current-utilizations-and-upcoming-frontiers
- Da Vinci Surgical System. Science Direct Medicine & Dentistry. https://www.sciencedirect.com/topics/medicine-and-dentistry/da-vinci-surgical-system
- Da Vinci Research and Outcomes. Intuitive. https://www.intuitive.com/en-us/about-us/company/research-outcomes
- Ricciardi, R. et al. (2025). The COMPARE Study: Comparing Perioperative Outcomes of Oncologic Minimally Invasive Laparoscopic, da Vinci Robotic, and Open Procedures. Annals of Surgery, 281(5): 748-763. DOI:10.1097/SLA.0000000000006572. https://journals.lww.com/annalsofsurgery/fulltext/2025/05000/the_compare_study__comparing_perioperative.8.aspx
- Geropoulos, G. et al. (2025). What Do Randomised Trials Reveal About Robotic Surgery? A Critical Appraisal Across Colorectal, Upper Gastrointestinal, Hepato-Pancreaticobiliary, and General Surgical Specialties. Journal of Clinical Medicine, 14(19), 6699. DOI:10.3390/jcm14196699. https://www.mdpi.com/2077-0383/14/19/6699
- Buffi, N.M. et al. (2025). Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures. World Journal of Urology 43, 348. DOI:10.1007/s00345-025-05732-z. https://link.springer.com/article/10.1007/s00345-025-05732-z
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.